agilon health, inc. (NYSE:AGL - Get Free Report) shares traded down 5% on Monday . The stock traded as low as $2.79 and last traded at $2.83. 480,161 shares were traded during trading, a decline of 90% from the average session volume of 4,923,468 shares. The stock had previously closed at $2.98.
Analyst Ratings Changes
Several research analysts have weighed in on the stock. Bank of America downgraded shares of agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price objective on the stock. in a report on Wednesday, October 2nd. Royal Bank of Canada restated an "outperform" rating and set a $8.00 price target on shares of agilon health in a research report on Wednesday, August 7th. Benchmark reiterated a "buy" rating and set a $9.00 target price on shares of agilon health in a research report on Thursday, August 8th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of agilon health from $5.00 to $4.00 and set a "hold" rating on the stock in a report on Friday, August 9th. Finally, Evercore ISI lowered their price target on shares of agilon health from $7.00 to $4.00 and set an "in-line" rating on the stock in a report on Tuesday, October 8th. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $8.03.
Get Our Latest Analysis on AGL
agilon health Price Performance
The stock has a market capitalization of $1.15 billion, a PE ratio of -4.00 and a beta of 0.54. The firm's 50 day simple moving average is $3.82 and its 200 day simple moving average is $5.22. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.36 and a quick ratio of 1.36.
agilon health (NYSE:AGL - Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). The firm had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.56 billion. agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The business's revenue was up 38.7% compared to the same quarter last year. During the same period last year, the firm posted ($0.04) earnings per share. As a group, equities analysts forecast that agilon health, inc. will post -0.32 EPS for the current fiscal year.
Insiders Place Their Bets
In other news, CEO Steven Sell bought 20,000 shares of the business's stock in a transaction dated Thursday, September 12th. The shares were purchased at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares of the company's stock, valued at approximately $227,102.40. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 3.20% of the company's stock.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in AGL. J.Safra Asset Management Corp grew its holdings in shares of agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company's stock worth $27,000 after purchasing an additional 3,625 shares during the last quarter. City State Bank bought a new position in shares of agilon health in the third quarter worth approximately $52,000. CWM LLC grew its holdings in shares of agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company's stock worth $59,000 after purchasing an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC bought a new position in shares of agilon health in the second quarter worth approximately $60,000. Finally, Bleakley Financial Group LLC bought a new stake in agilon health in the first quarter valued at $65,000.
agilon health Company Profile
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Recommended Stories
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.